Additional markers such as elevated platelet counts, nucleated red blood cells, and low albumin levels suggest that both inflammation and hypercoagulability further compound the risk of pulmonary hypertension [33,34]. The gene discussed is ALB; the disease is pulmonary arterial hypertension.